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Background
Transactive DNA binding protein (TDP-43) is the major
component of the ubiquitin-positive protein aggregates
seen in ~90% of Amyotrophic Lateral Sclerosis (ALS)
and 60% of Frontotemporal Lobar Degeneration (FTLD)
cases [1]. We have previously shown that mutations in
the gene encoding TDP-43 are causally linked to familial
ALS+/-FTLD [2] TDP-43 belongs to the heterogeneous
nuclear ribonucleoprotein (hnRNP) family of proteins
that are involved in the regulation of RNA transcription,
splicing, transport and translation [3]. There are a large
number of hnRNPs, many of which have overlapping
functions and often act cooperatively in RNA processing.
Here we sought to determine whether TDP-43 aggregates
contain other hnRNPs that might contribute to the
neurodegenerative process.
Materials and methods
Immunohistochemistry for 14 hnRNPs predicted to
associate with TDP-43 were examined in brain and
spinal cord tissues from 20 FTLD-TDP and ALS cases.
Co-localization with TDP-43 was examined using double-
labelling immunoflouresence. Expression of selected
hnRNPs was then examined in other neurodegenerative
cases and controls to determine the specificity of any
changes observed.
Results
One hnRNP demonstrated a striking accumulation within
dystrophic neurites and cytoplasmic inclusions in the fron-
tal cortex of FTLD-TDP cases. The hnRNP inclusions
were not detected in other neurodegenerative cases with
mutations of MAPT, FUS, SOD1 and C9ORF72. This par-
ticular hnRNP was found to co-localize with ~85% of
TDP-43 inclusions and ~67% of ubiquitin incluions,
largely in the frontal cortex and hippocampus of FTLD-
TDP cases. Interestingly, the inclusions were not seen in
FTLD-TDP cases with C9ORF72 mutation.
Conclusions
We have identified one hnRNP that is abundant within the
inclusions seen in FTLD-TDP cases. The hnRNP is seen to
colocalize with TDP-43 in the majority of cytoplasmic
inclusions in FTLD-TDP but not other neurodegenerative
disorders. The mechanistic implications of this interaction
with TDP-43 and the contribution of its sequestration into
inclusions towards neurodegeneration requires further
investigation.
Authors’ details
1Department of Clinical Neuroscience, Institute of Psychiatry, King’s College
London, London, UK. 2Department of Neuropathology, Institute of
Pathology, Medical and Health Science Centre, University of Debrecen.,
Debrecen, Hungary. 3Department of Biotechnology B3, Jozef Stefan Institute,
Jamova 39, Ljubljana, Slovenia.
Published: 13 September 2013
References
1. Neumann M, Sampathu D, Kwong L, Truax A, Micsenyi M, Chou T, Bruce J,
Schuck T, Grossman M, Clark C, McCluskey L, Miller B, Masliah E,
Mackenzie I, Feldman H, Kretzschmar H, Trojanowski J: Ubiquitinated TDP-
43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral
Sclerosis. Science 2006, 10:130-133.
2. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S,
Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD,
Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE: TDP-43 Mutations
in Familial and Sporadic ALS. Science 2008, 319:1668-1672.
3. Buratti E, Baralle FE: Multiple roles of TDP-43 in gene expression, splicing
regulation, and human disease. Front Biosci 2008, 13:867-878.
doi:10.1186/1750-1326-8-S1-P23
Cite this article as: Kattuah et al.: Analysis of TDP-43 and its binding
partners in neurodegenerative diseases. Molecular Neurodegeneration
2013 8(Suppl 1):P23.
1Department of Clinical Neuroscience, Institute of Psychiatry, King’s College
London, London, UK
Full list of author information is available at the end of the article
Kattuah et al. Molecular Neurodegeneration 2013, 8(Suppl 1):P23
http://www.molecularneurodegeneration.com/content/8/S1/P23
© 2013 Kattuah et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
